Literature DB >> 24518758

The role of KIR genes and their cognate HLA class I ligands in childhood acute lymphoblastic leukemia.

Adam J de Smith1, Kyle M Walsh, Martha B Ladner, Siming Zhang, Carmen Xiao, Franziska Cohen, Theodore B Moore, Anand P Chokkalingam, Catherine Metayer, Patricia A Buffler, Elizabeth A Trachtenberg, Joseph L Wiemels.   

Abstract

Killer cell immunoglobulin-like receptors (KIRs), via interaction with their cognate HLA class I ligands, play a crucial role in the development and activity of natural killer cells. Following recent reports of KIR gene associations in childhood acute lymphoblastic leukemia (ALL), we present a more in-depth investigation of KIR genes and their cognate HLA ligands on childhood ALL risk. Genotyping of 16 KIR genes, along with HLA class I groups C1/C2 and Bw4 supertype ligands, was carried out in 212 childhood ALL cases and 231 healthy controls. Frequencies of KIR genes, KIR haplotypes, and combinations of KIR-HLA ligands were tested for disease association using logistic regression analyses. KIR A/A genotype frequency was significantly increased in cases (33.5%) compared with controls (24.2%) (odds ratio [OR] = 1.57; 95% confidence interval [CI], 1.04-2.39). Stratifying analysis by ethnicity, a significant difference in KIR genotype frequency was demonstrated in Hispanic cases (34.2%) compared with controls (21.9%) (OR = 1.86; 95% CI, 1.05-3.31). Homozygosity for the HLA-Bw4 allele was strongly associated with increased ALL risk exclusively in non-Hispanic white children (OR = 3.93; 95% CI, 1.44-12.64). Our findings suggest a role for KIR genes and their HLA ligands in childhood ALL etiology that may vary among ethnic groups.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24518758      PMCID: PMC3990912          DOI: 10.1182/blood-2013-11-540625

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  44 in total

1.  KIR in type 1 diabetes: disparate distribution of activating and inhibitory natural killer cell receptors in patients versus HLA-matched control subjects.

Authors:  Arno R van der Slik; Bobby P C Koeleman; Willem Verduijn; G Jan Bruining; Bart O Roep; Marius J Giphart
Journal:  Diabetes       Date:  2003-10       Impact factor: 9.461

2.  HLA class I antigen and transporter associated with antigen processing (TAP1 and TAP2) down-regulation in high-grade primary breast carcinoma lesions.

Authors:  M Vitale; R Rezzani; L Rodella; G Zauli; P Grigolato; M Cadei; D J Hicklin; S Ferrone
Journal:  Cancer Res       Date:  1998-02-15       Impact factor: 12.701

3.  Human diversity in killer cell inhibitory receptor genes.

Authors:  M Uhrberg; N M Valiante; B P Shum; H G Shilling; K Lienert-Weidenbach; B Corliss; D Tyan; L L Lanier; P Parham
Journal:  Immunity       Date:  1997-12       Impact factor: 31.745

4.  HLA and NK cell inhibitory receptor genes in resolving hepatitis C virus infection.

Authors:  Salim I Khakoo; Chloe L Thio; Maureen P Martin; Collin R Brooks; Xiaojiang Gao; Jacquie Astemborski; Jie Cheng; James J Goedert; David Vlahov; Margaret Hilgartner; Steven Cox; Ann-Margeret Little; Graeme J Alexander; Matthew E Cramp; Stephen J O'Brien; William M C Rosenberg; David L Thomas; Mary Carrington
Journal:  Science       Date:  2004-08-06       Impact factor: 47.728

5.  Comparative genomic analysis, diversity and evolution of two KIR haplotypes A and B.

Authors:  Annalise M Martin; Jerzy K Kulski; Silvana Gaudieri; Campbell S Witt; Elizabeth M Freitas; John Trowsdale; Frank T Christiansen
Journal:  Gene       Date:  2004-06-23       Impact factor: 3.688

6.  Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer.

Authors:  F Momburg; T Degener; E Bacchus; G Moldenhauer; G J Hämmerling; P Möller
Journal:  Int J Cancer       Date:  1986-02-15       Impact factor: 7.396

Review 7.  The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism.

Authors:  Katharine C Hsu; Shohei Chida; Daniel E Geraghty; Bo Dupont
Journal:  Immunol Rev       Date:  2002-12       Impact factor: 12.988

8.  Locus-specific amplification of HLA class I genes from genomic DNA: locus-specific sequences in the first and third introns of HLA-A, -B, and -C alleles.

Authors:  N Cereb; P Maye; S Lee; Y Kong; S Y Yang
Journal:  Tissue Antigens       Date:  1995-01

9.  Cutting edge: susceptibility to psoriatic arthritis: influence of activating killer Ig-like receptor genes in the absence of specific HLA-C alleles.

Authors:  Maureen P Martin; George Nelson; Jeong-Hee Lee; Fawnda Pellett; Xiaojiang Gao; Judith Wade; Michael J Wilson; John Trowsdale; Dafna Gladman; Mary Carrington
Journal:  J Immunol       Date:  2002-09-15       Impact factor: 5.422

10.  Combinations of maternal KIR and fetal HLA-C genes influence the risk of preeclampsia and reproductive success.

Authors:  Susan E Hiby; James J Walker; Kevin M O'shaughnessy; Christopher W G Redman; Mary Carrington; John Trowsdale; Ashley Moffett
Journal:  J Exp Med       Date:  2004-10-11       Impact factor: 14.307

View more
  17 in total

1.  Genomic clues to ethnic differences in ALL.

Authors:  Sharon A Savage
Journal:  Blood       Date:  2014-04-17       Impact factor: 22.113

2.  Correlation between microsatellite discrepancy scores and transplant outcome after haemopoietic SCT for pediatric ALL.

Authors:  J Harvey; A Green; S J Groves; J Cornish; J Moppett; M Cummins; L Keen; S Culliford; A Poles; W Hulme; Y Li; C G Steward
Journal:  Bone Marrow Transplant       Date:  2015-01-12       Impact factor: 5.483

3.  Central nervous system acute lymphoblastic leukemia: role of natural killer cells.

Authors:  Liron Frishman-Levy; Avishai Shemesh; Allan Bar-Sinai; Chao Ma; Zhenya Ni; Shahar Frenkel; Vera Muench; Hilke Bruckmueller; Christian Vokuhl; Klaus-Michael Debatin; Cornelia Eckert; Martin Stanulla; Martin Schrappe; Kerry S Campbell; Ron Loewenthal; Denis M Schewe; Jacob Hochman; Lueder H Meyer; Dan Kaufman; Gunnar Cario; Angel Porgador; Shai Izraeli
Journal:  Blood       Date:  2015-04-20       Impact factor: 22.113

4.  Typing of killer-cell immunoglobulin-like receptors and their cognate human leukocyte antigen class I ligands predicts survival of Chinese Han patients with metastatic non-small-cell lung cancer.

Authors:  Hui Yu; Fang Liu; Benoit Sansas; Bin Kang; Xavier Preville; Xianghua Wu; Jianhua Chang; Romain Micol; Jialei Wang; Xia Meng
Journal:  Mol Clin Oncol       Date:  2016-12-12

5.  Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia.

Authors:  Julie R Gilbert; Himalee S Sabnis; Roman Radzievski; Deon B Doxie; Deborah DeRyckere; Sharon M Castellino; Kavita Dhodapkar
Journal:  J Immunother Cancer       Date:  2022-06       Impact factor: 12.469

6.  Delays in postremission chemotherapy for Philadelphia chromosome negative acute lymphoblastic leukemia are associated with inferior outcomes in patients who undergo allogeneic transplant: An analysis from ECOG 2993/MRC UK ALLXII.

Authors:  Anita J Kumar; Phyllis A Gimotty; Joel M Gelfand; Georgina Buck; Jacob M Rowe; Anthony H Goldstone; Adele Fielding; David I Marks; Mark Litzow; Elisabeth Paietta; Hillard M Lazarus; Martin S Tallman; Selina M Luger; Alison W Loren
Journal:  Am J Hematol       Date:  2016-08-22       Impact factor: 10.047

Review 7.  Allogeneic Hematopoietic Cell Transplantation for Myeloma: When and in Whom Does It Work.

Authors:  Qaiser Bashir; Muzaffar H Qazilbash
Journal:  Curr Hematol Malig Rep       Date:  2017-04       Impact factor: 3.952

8.  Killer cell immunoglobulin-like receptor gene cluster predisposes to susceptibility to B-cell acute lymphoblastic leukemia in Chinese children.

Authors:  Mingyan Jiang; Xia Guo; Lixing Yuan; Ju Gao; Li Huo; Qiang Li
Journal:  Int J Clin Exp Pathol       Date:  2020-03-01

9.  KIR-HLA profiling shows presence of higher frequencies of strong inhibitory KIR-ligands among prognostically poor risk AML patients.

Authors:  Meixin Shen; Yeh-Ching Linn; Ee-Chee Ren
Journal:  Immunogenetics       Date:  2015-12-09       Impact factor: 2.846

Review 10.  The Impact of KIR Polymorphism on the Risk of Developing Cancer: Not as Strong as Imagined?

Authors:  Danillo G Augusto
Journal:  Front Genet       Date:  2016-06-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.